Bari mu fara da tambayoyi guda biyu masu sauƙi. Idan masu mulki suna da bayanan da ke gare su game da yabo tsakanin ƙimar ingancin rigakafin Covid-19 a cikin gwaje-gwajen da aka sarrafa da tasirin su a cikin ainihin duniya, shin har yanzu za su ba da izinin amfani da gaggawa? Shin tsarin dokokinsu zai ba su damar yin hakan?
Ka tuna, duk dokoki suna aiki da manufa biyu. A gefe guda, suna halatta kuma suna ba da dama, suna ba da ikon yin wasu abubuwa. A daya hannun kuma, suna iyakancewa da hanawa, shingen shinge abin da za a iya yi bisa ka'ida ko da ta jiha.
Na biyu, shin gwamnatin anti-vaxxer da hukumar lafiya ke mulkin Denmark? Daga Yuli 1 Denmark, wanda ke da kyawawan kayan aikin kiwon lafiya ciki har da tattara bayanai, an haramta wa 'yan ƙasa da 18 rigakafin rigakafi kuma a tsakiyar Satumba. An tsawaita haramcin zuwa masu haɓakawa na ƙasa da 50s, ban da a cikin yanayi na musamman ga marasa lafiya da masu haɗari a cikin duka biyun.
Bayanin da hukumomin lafiya suka bayar yana da ban sha'awa ga abin da suka faɗa da abin da ba su faɗi ba. Suna tsammanin hauhawar cututtukan Covid-19 a cikin kaka da hunturu kuma "da nufin hana mummunar cuta, asibiti da mutuwa." Wannan haɗari ya shafi masu shekaru 50 da sama kuma ba ƙananan ba. Saboda ba a yi nufin rigakafin kamuwa da cutar ba, ba za a sake ba da su ga ’yan ƙasa da shekara 50 ba.
Koyaya, gwamnatoci ba sa hana samfuran kawai saboda ba su da fa'ida. Hannun sun shafi samfuran da ke haifar da lahani kawai. Don haka gaskiyar da ba a bayyana ba ita ce fa'ida: rabon cutarwa ba ya da kyau. Tambaya mai ban sha'awa don haka ita ce: me ya sa ba su faɗi haka ba? Bayanai masu ma'ana daga ko'ina cikin duniya suna nuna rashin kulawa ga tasirin allurar rigakafin rashin lafiya ga masu shekaru kasa da 50 masu lafiya da kuma babban haɗarin munanan abubuwan da suka faru. Hukuncin Denmark ya nuna a hukumance idan an yarda da kai cewa lahani ya fi fa'ida.
Asalin Bafulatani na Lockdown
Makulli a duk faɗin yammacin duniya ya kasance, a gare ni, ba za a iya bayyana su ba kuma abin mamaki. Yin watsi da tarin ilimin kimiyya na ƙarni na ƙima da tsare-tsaren shirye-shiryen rigakafin cutar ta duniya da na ƙasa ba bisa sabon kimiyya ba ne ko kuma bayanan da ke tasowa.
Maimakon haka, sun dogara ne da farko a kan ƙirar ƙira ta amfani da zato mara kyau, na biyu kuma akan bayanan da ba a sani ba daga China waɗanda manufofin mulkin mallaka suka taka rawar gani a cikin ma'aikatan kiwon lafiyarmu da 'yan siyasa, waɗanda manyan kafofin watsa labarai suka yaba. A ci gaba da nuna kyama ga ƙwaƙƙwaran ƙungiyar kimiyance, muryoyin da suka saba da juna a cikin cibiyoyin lafiya da na siyasa an rufe su kuma an kore su. A wajen gwamnati, an tozarta su tare da kore su daga dandalin jama'a ta hanyar hada baki da manyan masu fasahar sadarwar zamani.
A cikin Fabrairu 2020, lokacin da jirgin ruwa mai saukar ungulu Gimbiya lu'ulu'u Kentaro Iwata, kwararre kan cututtuka a jami'ar Kobe, ya bayyana shi a matsayin "mutane 3,711 a Yokohama.Covid-19 mil.” Barkewar iri cikin sauƙi a cikin jiragen ruwa na balaguro saboda yawan adadin tsofaffin fasinjoji masu rauni da ke zaune da kuma cuɗanya a cikin wuraren da aka killace.
Ko da a cikin waɗannan munanan yanayi, a ƙarƙashin kashi ɗaya bisa biyar na mutanen da aka kama sun kamu da cutar, ƙananan adadin waɗanda suka kamu da cutar sun mutu kuma 98.2% an dawo dasu. Yin amfani da bayanan da aka daidaita shekaru, Cibiyar Nazarin Shaida ta Jami'ar Oxford ta kiyasta adadin masu kamuwa da cuta (IFR) na 0.5% da adadin kisa (CFR) na 1.1% akan Gimbiya lu'ulu'u kuma, tun daga ranar 26 ga Maris, 2020, a IFR na duniya kusan 0.20% (idan aka kwatanta da mura na yanayi na 0.1% da Mutanen Espanya mura> 2.5% wanda ya kashe galibin mutane a cikin rukunin shekaru 20-40). Tabbatarwa, ko da na sama da 70s ba tare da cututtuka ba, IFR yana ƙasa da 1%.
Dukkanin wadannan bayanan ''hujja'' an jefar da su ne don nuna goyon baya ga bayanan da ba su da inganci gaba daya da kuma bidiyoyin karya daga kasar Sin wadanda aka shigar da su cikin tsarin ilmin lissafi don samar da al'amuran da suka faru a baya wadanda kafofin watsa labarai da gwamnatoci ke daukar su a matsayin hasashen. Hauka
Kwarewar Indiya: Ba lallai ba ne a yi amfani da allurar rigakafi don bugun baya da Covid
Kwarewar Indiya a tsakiyar 2021 ya tabbatar da cewa alluran rigakafi ba su da mahimmanci don murmurewa da sauri daga bala'in Covid. Duk wanda ya bi labarin Covid zai tuna da mugayen hotuna a cikin bazara-lokacin bazara na 2021 tare da gawarwakin da ke shawagi a bakin kogi kuma suna taruwa a wuraren konawa. Girgizar ya kasance kama da haka yayin hawan da gangar jikin, inda adadin wadanda suka mutu ya kai 1.06 ga mutane miliyan a ranar 20 ga Afrilu, wanda ya kai 2.98 a ranar 21 da 23 ga Mayu kuma ya koma 1.00 a ranar 24 ga Yuni (Hoto 1). A waɗancan kwanakin ukun cikakken ɗaukar allurar rigakafin Indiya ya kasance 1.26%, 2.96% da 3.53% na yawan jama'a, bi da bi.
Jama'a sun yi tambaya game da amincin bayanan, inda suka fito fili suna ba da kididdigar kididdigar da aka yi don rage kunyar siyasa. Sanin wani abu na Indiya, ban yarda ba kuma na lura fiye da alamar wariyar launin fata a cikin ɗaukar hoto. Komai. Ko da da gangan hukumomi sun danne alkaluman adadin wadanda suka mutu, zai zama wauta a ce sun yi haka tare da raguwar adadin. Matsakaicin haɓakawa da faɗuwar ya yi daidai da ƙwarewar yawancin ƙasashe masu raƙuman ƙwayar cuta a jere. Duk abin da zai iya bayyana faɗuwar, tabbas ba babban ɗaukar hoto ba ne. Kariyar garken garken ga bambance-bambancen Delta wanda ke da rinjaye a lokacin ta hanyar cuɗanya da cututtukan da ba a sarrafa su da ƙaramin allurar rigakafi, maiyuwa.
Wani mai fafutuka don bayanin shine yawan amfani da ivermectin. Rikicin tsakiyar watan Mayun bara, gwamnatin jihar Uttar Pradesh (jihar mafi yawan jama'a a Indiya mai mutane miliyan 200!), abin razana ita ce ta farko da ta ba da izinin yin amfani da ivermectin mai girma da rigakafin cutar ta Covid-19 a watan Mayu-Yuni 2020. Nazarin ya tabbatar da cewa "magungunan ya taimaka wa jihar ta ci gaba da samun raguwar mace-mace da kuma samun daidaito idan aka kwatanta da sauran jihohi. ”
Meta-bincike na Andrew Bryant da Tess Lawrie a cikin Jaridar Amurka ta Magunguna na gwaje-gwajen sarrafa bazuwar 24 (RCTs) a cikin ƙasashe 15 (ɗayan wanda aka ja daga baya azaman mai yuwuwa zamba) ya kammala cewa ivermectin yana taimakawa sosai don rigakafi da magance Covid-19 kuma, tare da raguwar mace-mace kashi 62%, na iya yuwuwar ceton miliyoyin rayuka. Sun buga a bincike mai biyo baya a cikin wannan mujallar da ta cire binciken da ake zargin kuma sakamakon har yanzu ya nuna ingantaccen tasirin ivermectin.
Nazarin RCT guda bakwai, wanda ke rufe marasa lafiya na 1,327, ta likitan Sweden Sebastian Rushworth An gano "raguwar kashi 62% a cikin haɗarin mutuwa tsakanin majinyatan Covid da aka yi wa ivermectin." Wani babban binciken kwanan nan daga Brazil wallafa a ranar 31 ga Agusta ya gano cewa, idan aka kwatanta da masu amfani da yau da kullun, rashin amfani da ivermectin ya kara haɗarin mace-mace masu alaƙa da Covid da sau 12.5 kuma ya mutu daga Covid sau bakwai.
Amma duk da haka saboda wani baƙon dalili, hukumomin kiwon lafiya na Yammacin Turai ba za su ba da shawarar ivermectin ba - ƙaramin farashi, kashe haƙƙin mallaka kuma babu wani magani mai fa'ida ga Big Pharma - ko ba da kuɗi mai tsauri amma gaskiya (wato, ba a tsara shi don gazawa ba) kimantawar asibiti game da ingancin sa a kan Covid. . Ya koma ciki Voldermectin: maganin da bai kamata a ambaci sunansa ba.
Kwarewar Duniya: Alurar rigakafi ba su isa su doke Covid ba
My A baya articles nuna dalilin da yasa lambobin Covid na Ostiraliya a wannan shekara sun nuna cewa alluran rigakafin ba su isa ba don hana kamuwa da cuta mai yawa, asibiti da mutuwa ko dai. Steve Kirsch ya sanar da masu biyan kuɗin Substack a ranar 17 ga Satumba zuwa na ciki Rahoton ga jam'iyyar Liberal Party of Canada a watan Yuni. Yana sanya karatun mai ban tausayi wanda ba zai zama abin mamaki ba ga dukanmu waɗanda suka ƙara yin kaurin suna game da hukumomin kiwon lafiyar jama'a da masu mulki. Rahoton ya zana bayanan hukuma na Ontario, ana sanar da shi ta hanyar malanta na kasa da kasa kuma ya jaddada cewa sakamakon da aka samu ya yi daidai da yanayin wasu larduna da kasashe na Kanada.
Cikakken allurar rigakafin ya nuna haɓakar shigar asibiti cikin watanni 5-6; Ƙarfafawa, a cikin makonni biyu kuma ya tashi bayan wasu watanni. Kariya ta hanyar kamuwa da cuta na iya wuce watanni 20. Alurar riga kafi yana nuna fa'idodi masu yawa ga sama da 70s da wasu fa'ida ga sama da 60s amma kusan babu fa'ida ga 'yan ƙasa da 60 dangane da asibiti da adadin mace-mace. Sabanin haka, abubuwan da ba su da kyau sun ta'allaka ne a cikin ƙungiyoyin shekaru 18-69, kuma musamman, a cikin tsari mafi ƙanƙanta, a cikin ƙungiyoyin shekaru 40-49, 50-59 da 30-39.
Saboda "yawan bayanai" ya nuna cewa alluran rigakafin ba su hana kamuwa da cuta, watsawa, asibiti da mace-mace ga 'yan kasa da shekaru 60, "kayan aikin kiwon lafiyar jama'a kamar, yakin neman rigakafin jama'a, umarni, fasfo da ƙuntatawa na balaguro suna buƙatar sake kimantawa. don dacewa." Factoring a cikin "sananan abubuwan da ba a sani ba da kuma abubuwan da ba a san su ba na dogon lokaci," "shaidar da aka bincika a cikin wannan rahoton… Gwamnati ta zauna kan wannan rahoto tun watan Yuni - abin mamaki.
A halin yanzu ana ci gaba da samun ƙaramin shaida a duniyar gaske cewa ƙasashen da ke da yawan adadin alluran rigakafi da yawa suna fama da ƙarancin mace-mace na Covid-19 (Hoto na 2 da 3). A cikin ginshiƙi guda biyu, Chile tana da duka mafi girman haɓakawa da mafi girman adadin mutuwar da ke da alaƙa da Covid, yayin da Indiya ke da mafi ƙarancin ɗaukar hoto amma mafi ƙarancin mace-mace na biyu.
Wasu masana suna nuna yanayin damuwa na karuwar mace-mace a tsakanin 'yan kasa da shekaru 14 a kasashen Turai 28. An Labari in maganin - zazzage fiye da sau 110,000 a preprint - da alama yana ba da shawara, duk da haka, cewa ƙarin haɗarin haɗari masu haɗari sun kasance 2.4 da 4.4 sau sama da raguwar haɗarin asibiti don allurar Moderna da Pfizer, bi da bi. Gargaɗi cewa rabon fa'ida zai bambanta da yawan jama'a a cikin bayanan haɗarin Covid daban-daban kuma a cikin lokuta daban-daban daga nazarin Moderna da Pfizer da suka yi nazari, marubutan sun kammala da buƙatar manyan gwaje-gwajen bazuwar don cimma matsaya mai ƙarfi. Zai taimaka idan Moderna da Pfizer za su saki granular, daidaitattun bayanan matakin da ke hannunsu.
a cikin wata bayanin kula akan Substack, biyu daga cikin marubutan binciken sun lura cewa adadin abubuwan da ba su dace ba na sauran alluran rigakafi shine 1-2 a kowace miliyan. An ja maganin cutar murar aladu (1976) bayan an danganta ta da ciwon Guillain-Barre a kashi 1 cikin 100,000. Idan aka kwatanta, gwaje-gwajen asibiti na Pfizer da Moderna sun nuna abubuwan da ba su dace ba 125 a cikin 100,000 da aka yi wa alurar riga kafi, tare da hana tsakanin 22-63 asibiti.
Wani sabon bincike na kusan yara 900,000 5-11 a North Carolina, wanda aka buga a cikin New England Journal of Medicine, yana ƙara damuwa da cewa allurar rigakafin ba kawai rasa tasirin su a cikin 'yan watanni ba; su kuma halakar da na halitta rigakafi a kan sake kamuwa da cuta mai tsanani wanda zai sa su a asibiti.
Panels C da D (marubuta binciken sun yi amfani da “Panel” maimakon “Chart”) a fili sun nuna cewa a tsakanin mutanen da ke kamuwa da bambance-bambancen Delta, kariya daga sake kamuwa da wanda ba a yi wa allurar rigakafin cutar ba ya dade fiye da na allurar. Tasirin tsohon har yanzu yana kan 50% bayan watanni takwas a watan Mayu 2022 yayin da na karshen ya fadi zuwa sifili (Hoto 4). Amma tare da bambance-bambancen Omicron, waɗanda suka kamu da cutar a baya sun ɗan fi samun maganin alurar riga kafi fiye da waɗanda ba a yi musu ba bayan watanni biyu (94.3:90.7%) kuma sun fi kyau bayan watanni huɗu (73.8:62.9%). Mai yuwuwa, ko da yake ba tabbatacce ba, bayani shine cewa allurar rigakafi da kansu suna lalata kariyar da ke tattare da rigakafi na halitta.
Sharhi uku game da Panels E da F (Hoto na 5). Na farko, yayin da x axis na Panel E yana cikin makonni, Panel F yana cikin watanni. Don haka ra'ayi na farko na gani na yaudara ne. Na biyu, iyakar tasirin maganin alurar riga kafi akan sake kamuwa da cuta mai tsanani don buƙatar shigar da asibiti yana kusa da 88%, ya kai kusan makonni huɗu bayan an fara allurar farko. Sabanin haka, tasirin farko na kamuwa da cuta da ya gabata shine 100% kuma ya kasance sama da kashi 95% (tuna yawan ingancin maganin da aka yi la'akari da shi 95%?) har sai bayan watanni bakwai.
Na uku, tasirin kamuwa da cutar da ta gabata game da sake kamuwa da cutar da ke buƙatar asibiti baya raguwa zuwa matakin daidai da mafi girman tasirin maganin har sai watanni tara bayan kamuwa da cuta. Wannan ita ce gaskiyar da CDC ta musanta har kwanan nan kuma ta yi amfani da ita a matsayin hujja don nuna bambanci tsakanin wadanda aka yi wa alurar riga kafi da wadanda ba a yi musu ba don samun damar shiga wuraren jama'a.
Ƙarshe uku sun biyo baya:
- Haɗarin sakamako mai tsanani ga yara daga kamuwa da cuta ta bambance-bambancen Covid na yanzu yayi ƙasa;
- Haɗarin mummunan sakamako daga alluran rigakafi ya fi girma, ma'ana allurar rigakafin cutarwa ce ga yara ƙanana - daidai dalilin da yasa Denmark ta haramta su ga yara;
- Fitar da yara masu lafiya ga haɗarin kamuwa da cuta na iya zama mafi kyau ga rigakafin mutum da na garken fiye da yawan yi musu alurar riga kafi.
FDA ba zai yiwu ta dawo da amincinta a matsayin mai kula da Amurka tare da bayyananniyar izgili da yawa cewa sabbin masu haɓaka bivalent an ba su izini bisa sakamakon gwaji daga beraye takwas. Farfesa Marty Makary daga Makarantar Kiwon Lafiyar Jama'a ta Johns Hopkins tweeted damuwarsa game da wannan da kuma game da sanarwar wani maganin rigakafi na shekara-shekara na Covid wanda ba a sarrafa shi ba kuma yayi watsi da rigakafi na halitta da kuma haɗarin haɗari. rigakafin rigakafi (inda tsarin rigakafi ya tuna da martaninsa na farko game da kamuwa da cuta ko alurar riga kafi ta hanyar da yawanci, amma ba koyaushe ba, yana raunana amsa ga bambance-bambancen pathogen iri ɗaya) daga dabarun rigakafi da yawa.
Daga mRNA Vaccine Hesitant zuwa Anti Vaxxer
The Financial Times - kamar yadda aka kafa na yau da kullun kamar yadda suke zuwa - kwanan nan sun yi gargadin cewa shawarar Amurka na fitar da sabbin harbe-harbe ba tare da gwajin asibiti kan mutane ba - wanda aka riga aka yiwa lakabi da maganin linzamin kwamfuta da wasu - haɗarin da ke lalata amincin jama'a da zurfafa jinkirin rigakafin. Eric Topol, wanda ya kafa kuma darektan Cibiyar Fassarar Bincike ta Scripps, ya ce "Mun riga mun sami matsalar amana a kasar nan kuma ba ma bukatar mu kara dagula lamarin." Duk da haka, ko da yayin da yake baƙin cikin rashin amincewa da jama'a ga masana kiwon lafiya da cibiyoyi, Topol kawai ya kasa taimakawa kansa kuma ya lalata Raba masu shakkar maganin alurar riga kafi da masu shakka a matsayin "anti-vaxxers, anti-kimiyya" mutane.
Ta haka ne ya nuna ainihin ilimin cututtukan da aka kwatanta da kyau Julie Sladden a cikin labarin in Mai kallo Ostiraliya a ranar 8 ga Satumba. Likitan Tasmania, "Da alama an sami ƙarin alluran rigakafi fiye da yawancin, an ba ni duka likita ne kuma na yi tafiya sosai," ta fara ba da uzurin ta na ƙin Covid jab tare da "'Ba ni da anti-vaxxer! Duk da haka, bayan shekaru biyu na “wariya da gwamnati ta amince da su da kuma wulaƙanta waɗanda suka yi amfani da haƙƙinsu na ƙin jab,” ta canza ra’ayinta.
Idan "anti-vaxxer" shine wanda ba zai iya ba da izini ga "alurar rigakafi" wanda ya kasa hana kamuwa da cuta ko watsawa, yana da alamun tsaro masu ban tsoro, dole ne a dauki shi don samun 'yancin rayuwa da aiki a cikin al'umma, don cutar da ke da fiye da kashi 99 cikin XNUMX na rayuwa na rayuwa, to, "e," Ni anti-vaxxer ... Gwamnatina ta yi haka.
Don wannan ya kamata mu ƙara yawan jinkirin jinkirin rigakafin cutar kanjamau zuwa sauran alluran rigakafin. A cikin al'amarina kafin cutar ta barke na shiga cikin hayyacinta don maganin mura na shekara-shekara da aka ba da shawarar ga alƙaluman shekaru na. Babu kuma. Kwarewar Covid ta kashe amanata ga masana'antar kiwon lafiya da lafiyar jama'a kuma, bayan da na yi nawa bincike, yanzu cikin ladabi na ƙi allurar mura kafin lokacin hunturu.
-
Ramesh Thakur, Babban Babban Masanin Cibiyar Brownstone, tsohon Mataimakin Sakatare-Janar na Majalisar Dinkin Duniya ne, kuma farfesa na farko a Makarantar Siyasa ta Crawford, Jami'ar Kasa ta Australiya.
Duba dukkan posts
